nuMoM2b Heart Health Study

Inclusion Criteria: Interval Contact: * Agreed to contact for future studies during nuMoM2b and not subsequently withdrawn from the cohort. * Have pregnancy outcome data from the nuMoM2b study. * At least 18 years of age (to begin interval contact attempts once nuMoM2b participant reaches age 18). * Provision of verbal consent for telephone interview or acknowledgement of consent with completion of the web-based self-administered questionnaire. In-clinic Visit: * Consented for participation in interval contacts and not subsequently withdrawn * Between 2 and 3.5 years after the nuMoM2b pregnancy ended * Self-report at least 6 months postpartum from any subsequent pregnancy * Self-report not currently pregnant * Able to provide informed consent * Provision of written, signed, informed consent for the 2 to 3.5 year in-clinic assessment * Not currently pregnant by urine pregnancy test administered in the clinic following consent In-home Sleep Breathing Assessment after the In-Clinic Visit: * Participation in the in-clinic visit * Participation in the sleep breathing substudy of nuMoM2b with at least one sleep breathing assessment providing valid data * Not currently using positive airway pressure (PAP) therapy or other approved treatments for sleep apnea such as oral appliances and nasal therapy patch (Provent) * Not currently on continuous oral steroid therapy for 14 days or more to treat asthma * Not currently using oxygen supplementation to treat a medical condition * Ab…